Steffen S.
- Country
- Germany
- Department
- #1205: pädiatrisches Klinisch-Pharmakologisches Studienzentrum (paedKliPS)
Research Overview
- Long-term neuropsychologic outcome of pre-emptive mTOR inhibitor treatment in children with tuberous sclerosis complex (TSC) under 4 months of age (PROTECT)
- Phase 3 Double-Blind Study of Zorevunersen Sodium in Reducing Major Motor Seizure Frequency in Dravet Syndrome Patients
- Efficacy and Safety of Alpelisib in Pediatric and Adult Patients with PIK3CA-Related Overgrowth Spectrum: A Phase II Randomized, Placebo-Controlled Study
Data & Insights
Has run more than one trial at 17 of 57 partner sites.
Specializations
Neurological Disorders
This investigator specializes in the study of tuberous sclerosis complex (TSC), focusing particularly on early intervention strategies in pediatric patients.
- Early-age neurological interventions
- Pediatric TSC management
- Developmental neurology
Their research encompasses neurological assessments in infants under 4 months of age.
Developmental Medicine
The investigator concentrates on neuropsychologic outcomes in young children, utilizing specialized assessment tools for cognitive development evaluation.
- Cognitive development assessment
- Infant developmental monitoring
- Long-term outcome studies
Their work involves comprehensive evaluation of developmental milestones in young patients.
Therapeutic Innovation
The investigator explores mTOR inhibitor treatments in pediatric populations, focusing on pre-emptive therapeutic approaches.
- Preventive treatment strategies
- Early therapeutic intervention
- Standard of care optimization
Their research examines innovative treatment approaches for genetic disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.